Quantitative Assessment of Iron Accumulation in the Deep Gray Matter of Multiple Sclerosis by Magnetic Field Correlation Imaging
暂无分享,去创建一个
J A Helpern | Y Ge | R I Grossman | J. Helpern | J. Babb | Hanzhang Lu | J. Jensen | R. Grossman | M. Inglese | Y. Ge | J. Herbert | L. Miles | J S Babb | M Inglese | H. Lu | J Herbert | H Lu | J H Jensen | R. Grossman | L Miles | J. Babb
[1] L G Nyúl,et al. Numerical tissue characterization in MS via standardization of the MR image intensity scale , 2000, Journal of magnetic resonance imaging : JMRI.
[2] E. Morgan,et al. The Metabolism of Neuronal Iron and Its Pathogenic Role in Neurological Disease: Review , 2004, Annals of the New York Academy of Sciences.
[3] R. Ordidge,et al. The measurement of R2, R2* and R2' in HIV-infected patients using the prime sequence as a measure of brain iron deposition. , 1997, Magnetic resonance imaging.
[4] J. Bulte,et al. Study of relapsing remitting experimental allergic encephalomyelitis SJL mouse model using MION‐46L enhanced in vivo MRI: Early histopathological correlation , 1998, Journal of Neuroscience Research.
[5] J. Connor,et al. Iron and neurodegenerative disorders , 2001, Brain Research Bulletin.
[6] W Craelius,et al. Iron deposits surrounding multiple sclerosis plaques. , 1982, Archives of pathology & laboratory medicine.
[7] T. S. St. Pierre,et al. Bi-exponential proton transverse relaxation rate (R2) image analysis using RF field intensity-weighted spin density projection: potential for R2 measurement of iron-loaded liver. , 2003, Magnetic resonance imaging.
[8] P. Matthews,et al. Thalamic neurodegeneration in multiple sclerosis , 2002, Annals of neurology.
[9] Joseph A. Helpern,et al. Quantitative MRI assessment of Alzheimer’s disease , 2007, Journal of Molecular Neuroscience.
[10] P. Doherty,et al. Inhibition of autoimmune neuropathological process by treatment with an iron-chelating agent , 1984, The Journal of experimental medicine.
[11] Massimo Filippi,et al. Multiple sclerosis: a white matter disease with associated gray matter damage , 2001, Journal of the Neurological Sciences.
[12] J. Beard,et al. Iron-deficient mice fail to develop autoimmune encephalomyelitis. , 2003, The Journal of nutrition.
[13] Jim Mintz,et al. Brain ferritin iron as a risk factor for age at onset in neurodegenerative diseases , 2005, Alzheimer's & Dementia.
[14] R. Herfkens,et al. Magnetic resonance imaging in multiple sclerosis: Decreased signal in thalamus and putamen , 1987, Annals of neurology.
[15] Glyn Johnson,et al. Magnetic field correlation imaging , 2006, Magnetic resonance in medicine.
[16] B. Drayer,et al. Reduced signal intensity on MR images of thalamus and putamen in multiple sclerosis: increased iron content? , 1987, AJR. American journal of roentgenology.
[17] S. LeVine,et al. The Role of Iron in the Pathogenesis of Experimental Allergic Encephalomyelitis and Multiple Sclerosis , 2004, Annals of the New York Academy of Sciences.
[18] R. Bakshi,et al. T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study. , 2002, Archives of neurology.
[19] Rohit Bakshi,et al. Prediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T2 hypointensity. , 2005, Archives of neurology.
[20] C. W. Tjoa,et al. MRI T2 hypointensity of the dentate nucleus is related to ambulatory impairment in multiple sclerosis , 2005, Journal of the Neurological Sciences.
[21] Supun Samarasekera,et al. Multiple sclerosis lesion quantification using fuzzy-connectedness principles , 1997, IEEE Transactions on Medical Imaging.
[22] R. Bakshi,et al. Gray matter T2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients , 2001, Journal of the Neurological Sciences.
[23] S. Sorbi,et al. Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years. , 2001, Archives of neurology.
[24] Dewey Odhner,et al. 3DVIEWNIX: an open, transportable, multidimensional, multimodality, multiparametric imaging software system , 1994, Medical Imaging.
[25] Mark A. Smith,et al. Mechanisms by which metals promote events connected to neurodegenerative diseases , 2001, Brain Research Bulletin.
[26] W. Macklin,et al. Iron‐enriched oligodendrocytes: A reexamination of their spatial distribution , 1990, Journal of neuroscience research.
[27] Robert Zivadinov,et al. Semi-automatic brain region extraction (SABRE) reveals superior cortical and deep gray matter atrophy in MS , 2006, NeuroImage.
[28] Alireza Minagar,et al. Gray Matter Involvement in Multiple Sclerosis: A New Window into Pathogenesis , 2003, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[29] P. Jezzard,et al. Thalamic neurodegeneration in relapsing-remitting multiple sclerosis , 2003, Neurology.
[30] I. Moseley,et al. Signal intensity on MRI of basal ganglia in multiple sclerosis. , 1995, Journal of neurology, neurosurgery, and psychiatry.
[31] H. Schipper,et al. Proinflammatory cytokines promote glial heme oxygenase‐1 expression and mitochondrial iron deposition: implications for multiple sclerosis , 2001, Journal of neurochemistry.
[32] S. LeVine,et al. Desferrioxamine suppresses experimental allergic encephalomyelitis induced by MBP in SJL mice , 1998, Journal of Neuroimmunology.
[33] Christine D. Dijkstra,et al. Reactive oxygen species are involved in the pathogenesis of experimental allergic encephalomyelitis in Lewis rats , 1995, Journal of Neuroimmunology.
[34] W. Bradley,et al. Iron accumulation in the basal ganglia following severe ischemic-anoxic insults in children. , 1988, Radiology.
[35] S. LeVine,et al. Iron deposits in the central nervous system of SJL mice with experimental allergic encephalomyelitis. , 1998, Life sciences.
[36] R I Grossman,et al. Three-dimensional proton spectroscopy of deep gray matter nuclei in relapsing–remitting MS , 2004, Neurology.